Fleck, D.* ; Voss, M.* ; Brankatschk, B.* ; Giudici, C.* ; Hampel, H.* ; Schwenk, B.M.* ; Edbauer, D.* ; Fukumori, A.* ; Steiner, H.* ; Kremmer, E. ; Haug-Kröeper, M.* ; Rossner, M.J.* ; Fluhrer, R.* ; Willem, M.* ; Haass, C.*
Proteolytic processing of Neuregulin 1 type III by three intramembrane cleaving proteases.
J. Biol. Chem. 291, 318-333 (2016)
Numerous membrane-bound proteins undergo regulated intramembrane proteolysis (RIP). RIP is initiated by shedding and the remaining stubs are further processed by intramembrane cleaving proteases (I-CLiPs). Neuregulin 1 type III (NRG1 type III) is a major physiological substrate of β-secretase (β-site APP cleaving enzyme 1; BACE1). BACE1-mediated cleavage is required to allow signaling of NRG1 type III. Due to the hairpin nature of NRG1 type III two membrane-bound stubs with a type 1 and a type 2 orientation are generated by proteolytic processing. We demonstrate that these stubs are substrates for three I-CLiPs. The type 1 oriented stub is further cleaved by γ-secretase at an ε-like site 5 amino acids N-terminal to the C-terminal membrane anchor and at a γ-like site in the middle of the transmembrane domain. The ε-cleavage site is only 1 amino acid N-terminal to a V/L substitution associated with schizophrenia. The mutation reduces generation of the NRG1 type III β-peptide as well as reverses signaling. Moreover, it affects the cleavage precision of γ-secretase at the γ-site similar to certain Alzheimer's disease associated mutations within the Amyloid precursor protein. The type 2 oriented membrane-retained stub of NRG1 type III is further processed by signal peptide peptidase-like proteases SPPL2a and SPPL2b. Expression of catalytically inactive aspartate mutations as well as treatment with (Z-LL)2 ketone inhibits formation of a N-terminal ICD and the corresponding secreted C-peptide. Thus, NRG1 type III is the first protein substrate, which is not only cleaved by multiple sheddases but also processed by three different I-CLiPs.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Adam ; Alzheimer Disease ; Amyloid-beta (ab) ; Beta-secretase 1 (bace1) ; Gamma-secretase ; Neurodegeneration
Keywords plus
Language
english
Publication Year
2016
Prepublished in Year
2015
HGF-reported in Year
2015
ISSN (print) / ISBN
0021-9258
e-ISSN
1083-351X
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 291,
Issue: 1,
Pages: 318-333
Article Number: ,
Supplement: ,
Series
Publisher
American Society for Biochemistry and Molecular Biology
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
CF Monoclonal Antibodies (CF-MAB)
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502210-001
Grants
Copyright
Erfassungsdatum
2015-12-07